Mosaic ImmunoEngineering Competitors and Similar CompaniesClear all
NextCure's competitors and similar companies include TC BioPharm.
 NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. |  TC BioPharm TC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products. | |
Founding Date | Founding Date 2015 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Beltsville, US HQ | Locations Holytown, GB HQ Leiden, NL Edinburgh, GB London, GB |
Employees | Employees N/A | Employees 41 |
Valuation ($) | Valuation ($) 39.2 m | Valuation ($) 926.7 k |
Financial | ||
Net income | Net income ($55.8m) (FY, 2025) | Net income (£12.2m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 160m | Total funding raised $ 33.2m |
For sources of this data, please see the company profile
View Company Profiles
TC BioPharm
HQ
Holytown, GB
Employees
41
TC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products.
View company